These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9704253

  • 1. Elevated serum TNF-alpha concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes.
    Alexandrakis M, Coulocheri S, Xylouri I, Ganotakis E, Eliakis P, Karkavitsas N, Eliopoulos GD.
    Haematologia (Budap); 1998; 29(1):13-24. PubMed ID: 9704253
    [Abstract] [Full Text] [Related]

  • 2. Measurement of serum cytokine levels in patients with myelodysplastic syndromes.
    Verhoef GE, De Schouwer P, Ceuppens JL, Van Damme J, Goossens W, Boogaerts MA.
    Leukemia; 1992 Dec; 6(12):1268-72. PubMed ID: 1280751
    [Abstract] [Full Text] [Related]

  • 3. Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance.
    Passam FH, Tsirakis G, Boula A, Fragou A, Consolas I, Alegakis A, Kyriakou DS, Alexandrakis MG.
    Clin Lab Haematol; 2004 Dec; 26(6):391-5. PubMed ID: 15595996
    [Abstract] [Full Text] [Related]

  • 4. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes.
    Berer A, Jäger E, Sagaster V, Streubel B, Wimazal F, Sperr WR, Welterman A, Schwarzinger I, Frommlet F, Haas OA, Valent P, Lechner K, Geissler K, Ohler L.
    Ann Hematol; 2003 May; 82(5):271-7. PubMed ID: 12739063
    [Abstract] [Full Text] [Related]

  • 5. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
    Alexandrakis MG, Passam FH, Pappa CA, Sfiridaki K, Tsirakis G, Damilakis J, Stathopoulos EN, Kyriakou DS.
    Leuk Res; 2005 Jan; 29(1):41-6. PubMed ID: 15541473
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of tumour necrosis factor-alpha predict response to recombinant human erythropoietin in patients with myelodysplastic syndrome.
    Stasi R, Brunetti M, Bussa S, Conforti M, Martin LS, La Presa M, Bianchi M, Parma A, Pagano A.
    Clin Lab Haematol; 1997 Sep; 19(3):197-201. PubMed ID: 9352145
    [Abstract] [Full Text] [Related]

  • 7. Low serum levels of tumor necrosis factor and interleukin-1 beta in myelodysplastic syndromes responsive to recombinant erythropoietin.
    Musto P, Matera R, Minervini MM, Checchia-de Ambrosio C, Bodenizza C, Falcone A, Carotenuto M.
    Haematologica; 1994 Sep; 79(3):265-8. PubMed ID: 7926977
    [Abstract] [Full Text] [Related]

  • 8. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
    Wu LY, Li X, Chang CK, Ying SX, Pu Q.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
    [Abstract] [Full Text] [Related]

  • 9. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
    Stifter G, Heiss S, Gastl G, Tzankov A, Stauder R.
    Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
    [Abstract] [Full Text] [Related]

  • 10. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
    Nagaki M, Iwai H, Naiki T, Ohnishi H, Muto Y, Moriwaki H.
    J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
    [Abstract] [Full Text] [Related]

  • 11. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
    Breccia M, Mengarelli A, Mancini M, Biondo F, Gentilini F, Latagliata R, Mandelli F, Alimena G.
    Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of serum cytokine concentrations in patients with infective endocarditis.
    Rawczynska-Englert I, Hryniewiecki T, Dzierzanowska D.
    J Heart Valve Dis; 2000 Sep; 9(5):705-9. PubMed ID: 11041188
    [Abstract] [Full Text] [Related]

  • 13. [Prediction of survival in myelodysplastic syndrome. Analysis of 2 scoring systems with prognostic value].
    Sanz GF, Sanz MA, Vallespí T, Cañizo MC, García S, Torrabadella M, San Miguel JF, Irriguible D.
    Sangre (Barc); 1989 Feb; 34(1):41-6. PubMed ID: 2711284
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.
    Küpeli E, Karnak D, Beder S, Kayacan O, Tutkak H.
    Respiration; 2008 Feb; 75(1):73-8. PubMed ID: 17975298
    [Abstract] [Full Text] [Related]

  • 15. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma.
    Zhang GJ, Adachi I.
    Anticancer Res; 1999 Feb; 19(2B):1427-32. PubMed ID: 10365118
    [Abstract] [Full Text] [Related]

  • 16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [Abstract] [Full Text] [Related]

  • 17. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P, Kamińska J, Kowalska M, Ruka W, Steffen J.
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [Abstract] [Full Text] [Related]

  • 18. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
    Dalamaga M, Karmaniolas K, Chamberland J, Nikolaidou A, Lekka A, Dionyssiou-Asteriou A, Mantzoros CS.
    Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
    [Abstract] [Full Text] [Related]

  • 19. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W.
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [Abstract] [Full Text] [Related]

  • 20. [[The role of TNF-alpha in myelodysplastic syndrome: immunoserologic and immunohistochemical studies] ].
    Molnár L, Berki T, Hussain A, Németh P, Losonczy H.
    Orv Hetil; 2000 Aug 13; 141(33):1807-11. PubMed ID: 10979309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.